Ligand id: 8458

Name: otelixizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
8864 otelixizumab
ChAglyCD3 | TRX4
Otelixizumab is a chimeric humanized IgG1 monoclonal antibody targeting the CD3E component of the T cell receptor. The antibody is aglycosylated. Otelixizumab was investigated as a potential treatment for autoimmune diseases including type I diabetes [3-4].
Peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Database Links
Specialist databases
IMGT/mAb-DB 235
Other databases
GtoPdb PubChem SID 252166668
Search PubMed clinical trials otelixizumab
Search PubMed titles otelixizumab
Search PubMed titles/abstracts otelixizumab
Wikipedia Otelixizumab